The value of plants used in traditional medicine for drug discovery.

Fabricant DS, Farnsworth NR. · 2001

Read The value of plants used in traditional medicine for drug discovery. by Fabricant DS, Farnsworth NR. (2001) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1240543.txt.

Introduction

Fabricant and Farnsworth made the case for folk medicine plants in drug hunting in 2001. Traditional healers have used plants as medicine for centuries. That record may point chemists to useful new drugs. The authors compare ways to pick plants for study.

They counted 122 proven drug compounds drawn from just 94 plant species. For 80 percent, folk use matched or related to modern use. That match rate is far above random picking. Fabricant also weighs costs and limits of plant-based searches. Old remedies, they argue, remain a rich lead source. The review also lists the pros and cons of plant-based drug searches in full.

Catalog record

CREATORFabricant DS, Farnsworth NR.
YEAR2001
COLLECTIONPAPERS
FORMATTXT
FILE SIZE11 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC1240543

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The value of plants used in traditional medicine for drug discovery. By D S Fabricant, N R Farnsworth Published in: Environmental Health Perspectives DOI: 10.1289/ehp.01109s169 ABSTRACT Abstract In this review we describe and discuss several approaches to selecting higher plants as candidates for drug development with the greatest possibility of success. We emphasize the role of information derived from various systems of traditional medicine (ethnomedicine) and its utility for drug discovery purposes. We have identified 122 compounds of defined structure, obtained from only 94 species of plants, that are used globally as drugs and demonstrate that 80% of these have had an ethnomedical use identical or related to the current use of the active elements of the plant. We identify and discuss advantages and disadvantages of using plants as starting points for drug development, specifically those used in traditional medicine. FULL TEXT The Full Text of this article is available as a PDF (323.8 KB). SELECTED REFERENCES These references are in PubMed. This may not be the complete list of references from this article. Baker J. T., Borris R. P., Carté B., Cordell G. A., Soejarto D. D., Cragg G. M., Gupta M. P., Iwu M. M., Madulid D. R., Tyler V. E. Natural product drug discovery and development: new perspectives on international collaboration. J Nat Prod. 1995 Sep;58(9):1325–1357. doi: 10.1021/np50123a003.Bhakuni D. S., Dhar M. L., Dhar M. M., Dhawan B. N., Gupta B., Srimal R. C. Screening of Indian plants for biological activity. 3. Indian J Exp Biol. 1971 Jan;9(1):91–102.Bhakuni D. S., Dhar M. L., Dhar M. M., Dhawan B. N., Mehrotra B. N. Screening of Indian plants for biological activity. II. Indian J Exp Biol. 1969 Oct;7(4):250–262.Bierer D. E., Dubenko L. G., Zhang P., Lu Q., Imbach P. A., Garofalo A. W., Phuan P. W., Fort D. M., Litvak J., Gerber R. E. Antihyperglycemic activities of cryptolepine analogues: an ethnobotanical lead structure isolated from Cryptolepis sanguinolenta. J Med Chem. 1998 Jul 16;41(15):2754–2764. doi: 10.1021/jm970735n.Bierer D. E., Fort D. M., Mendez C. D., Luo J., Imbach P. A., Dubenko L. G., Jolad S. D., Gerber R. E., Litvak J., Lu Q. Ethnobotanical-directed discovery of the antihyperglycemic properties of cryptolepine: its isolation from Cryptolepis sanguinolenta, synthesis, and in vitro and in vivo activities. J Med Chem. 1998 Mar 12;41(6):894–901. doi: 10.1021/jm9704816.Bonet M. A., Parada M., Selga A., Vallès J. Studies on pharmaceutical ethnobotany in the regions of L'Alt Empordà and Les Guilleries (Catalonia, Iberian Peninsula). J Ethnopharmacol. 1999 Dec 15;68(1-3):145–168. doi: 10.1016/s0378-8741(99)00083-5.Carney J. R., Krenisky J. M., Williamson R. T., Luo J., Carlson T. J., Hsu V. L., Moswa J. L. Maprouneacin, a new daphnane diterpenoid with potent antihyperglycemic activity from Maprounea africana. J Nat Prod. 1999 Feb;62(2):345–347. doi: 10.1021/np980356c.Clark A. M. Natural products as a resource for new drugs. Pharm Res. 1996 Aug;13(8):1133–1144. doi: 10.1023/a:1016091631721.Cragg G. M., Boyd M. R., Cardellina J. H., 2nd, Newman D. J., Snader K. M., McCloud T. G. Ethnobotany and drug discovery: the experience of the US National Cancer Institute. Ciba Found Symp. 1994;185:178–196. doi: 10.1002/9780470514634.ch13.Cragg G. M., Newman D. J., Snader K. M. Natural products in drug discovery and development. J Nat Prod. 1997 Jan;60(1):52–60. doi: 10.1021/np9604893.Dhar M. L., Dhar M. M., Dhawan B. N., Mehrotra B. N., Ray C. Screening of Indian plants for biological activity: I. Indian J Exp Biol. 1968 Oct;6(4):232–247.Dhar M. L., Dhar M. M., Dhawan B. N., Mehrotra B. N., Srimal R. C., Tandon J. S. Screening of Indian plants for biological activity. IV. Indian J Exp Biol. 1973 Jan;11(1):43–54.Dhar M. L., Dhawan B. N., Prasad C. R., Rastogi R. P., Singh K. K., Tandon J. S. Screening of Indian plants for biological activity : Part V. Indian J Exp Biol. 1974 Nov;12(6):512–523.Dhawan B. N., Dubey M. P., Mehrotra B. N., Rastogi R. P., Tandon J. S. Screening of Indian plants for biological activity: Part IX. Indian J Exp Biol. 1980 Jun;18(6):594–606.Dhawan B. N., Patnaik G. K., Rastogi R. P., Singh K. K., Tandon J. S. Screening of Indian plants for biological activity: part VI. Indian J Exp Biol. 1977 Mar;15(3):208–219.Douros J., Suffness M. New natural products under development at the National Cancer Institute. Recent Results Cancer Res. 1981;76:153–175. doi: 10.1007/978-3-642-81565-2_14.Douros J., Suffness M. The National Cancer Institute's Natural Products Antineoplastic Development Program. Recent Results Cancer Res. 1980;70:21–44. doi: 10.1007/978-3-642-81392-4_3.Farnsworth N. R., Akerele O., Bingel A. S., Soejarto D. D., Guo Z. Medicinal plants in therapy. Bull World Health Organ. 1985;63(6):965–981.Farnsworth N. R. Biological and phytochemical screening of plants. J Pharm Sci. 1966 Mar;55(3):225–276. doi: 10.1002/jps.2600550302.Farnsworth N. R. Ethnopharmacology and drug development. Ciba Found Symp. 1994;185:42–59. doi: 10.1002/9780470514634.ch4.Farnsworth N. R. The role of ethnopharmacology in drug development. Ciba Found Symp. 1990;154:2–21. doi: 10.1002/9780470514009.ch2.Harvey A. Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today. 2000 Jul;5(7):294–300. doi: 10.1016/s1359-6446(00)01511-7.Kashman Y., Gustafson K. R., Fuller R. W., Cardellina J. H., 2nd, McMahon J. B., Currens M. J., Buckheit R. W., Jr, Hughes S. H., Cragg G. M., Boyd M. R. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum. J Med Chem. 1992 Jul 24;35(15):2735–2743. doi: 10.1021/jm00093a004.King S. R., Carlson T. J., Moran K. Biological diversity, indigenous knowledge, drug discovery and intellectual property rights: creating reciprocity and maintaining relationships. J Ethnopharmacol. 1996 Apr;51(1-3):45–57. doi: 10.1016/0378-8741(95)01349-0.Kinghorn A. D. The discovery of drugs from higher plants. Biotechnology. 1994;26:81–108. doi: 10.1016/b978-0-7506-9003-4.50010-1.Loub W. D., Farnsworth N. R., Soejarto D. D., Quinn M. L. NAPRALERT: computer handling of natural product research data. J Chem Inf Comput Sci. 1985 May;25(2):99–103. doi: 10.1021/ci00046a009.Luo J., Cheung J., Yevich E. M., Clark J. P., Tsai J., Lapresca P., Ubillas R. P., Fort D. M., Carlson T. J., Hector R. F. Novel terpenoid-type quinones isolated from Pycnanthus angolensis of potential utility in the treatment of type 2 diabetes. J Pharmacol Exp Ther. 1999 Feb;288(2):529–534.Luo J., Chuang T., Cheung J., Quan J., Tsai J., Sullivan C., Hector R. F., Reed M. J., Meszaros K., King S. R. Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata). Eur J Pharmacol. 1998 Apr 3;346(1):77–79. doi: 10.1016/s0014-2999(98)00139-3.Luo J., Fort D. M., Carlson T. J., Noamesi B. K., nii-Amon-Kotei D., King S. R., Tsai J., Quan J., Hobensack C., Lapresca P. Cryptolepis sanguinolenta: an ethnobotanical approach to drug discovery and the isolation of a potentially useful new antihyperglycaemic agent. Diabet Med. 1998 May;15(5):367–374. doi: 10.1002/(SICI)1096-9136(199805)15:5<367::AID-DIA576>3.0.CO;2-G.Mebs D. Notes on the traditional use of plants to treat snake bite in northern Papua New Guinea. Toxicon. 2000 Feb;38(2):299–302. doi: 10.1016/s0041-0101(99)00148-8.Merzouki A., Ed-derfoufi F., Molero Mesa J Contribution to the knowledge of Rifian traditional medicine. II: Folk medicine in Ksar Lakbir district (NW Morocco). Fitoterapia. 2000 Jun;71(3):278–307. doi: 10.1016/s0367-326x(00)00139-8.Ndubani P., Höjer B. Traditional healers and the treatment of sexually transmitted illnesses in rural Zambia. J Ethnopharmacol. 1999 Oct;67(1):15–25. doi: 10.1016/s0378-8741(99)00075-6.Newman D. J., Cragg G. M., Snader K. M. The influence of natural products upon drug discovery. Nat Prod Rep. 2000 Jun;17(3):215–234. doi: 10.1039/a902202c.Noumi E., Dibakto T. W. Medicinal plants used for peptic ulcer in the Bangangte region, western Cameroon. Fitoterapia. 2000 Aug;71(4):406–412. doi: 10.1016/s0367-326x(00)00144-1.Ogura M., Cordell G. A., Quinn M. L., Leon C., Benoit P. S., Soejarto D. D., Farnsworth N. R. Ethnopharmacologic studies. I. Rapid solution to a problem--oral use of Heliopsis longipes--by means

Read the complete text